InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: finesand post# 23194

Monday, 06/11/2018 10:51:21 AM

Monday, June 11, 2018 10:51:21 AM

Post# of 232880
Yes, 35 subjects have entered the extension study. The primary efficacy endpoint for this study was pegged to 0.05log or greater reduction in
HIV-1 RNA viral load from baseline at the end of the 1 week double blind treatment period. I did not find any reference to another viral reduction value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News